• Dehydroepiandrosterone (DHEA): Mechanisms & Uses

  2026-09-17

  Dehydroepiandrosterone (DHEA) is an endogenous steroid precursor and neurosteroid used to study neuroprotection, apoptosis inhibition, neural stem-cell biology, and ovarian models. Its research value depends on separating cell-survival benchmarks from endocrine-model induction, especially in DHEA-induced polycystic ovary syndrome studies.

• UBR1 and UBR2 in Mammalian ER Stress Sensing

  2026-09-17

  The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its findings connect N-degron pathway activity with ER stress adaptation and show that loss of either factor increases susceptibility to ER stress-induced apoptosis.

• Total RNA Extraction Reagent (Trizol) for Bacillus Studies

  2026-09-16

  Total RNA Extraction Reagent (Trizol) can connect transcriptional evidence with protein-engineering outcomes in Bacillus enzyme production. This article explains how an RNA-centered workflow complements the 2026 protein-glutaminase study without confusing transcript abundance with catalytic performance.

• Topotecan in First-Line Small Cell Lung Cancer

  2026-09-16

  This clinical review evaluates whether topotecan-based combinations could extend first-line treatment options for small cell lung cancer beyond cisplatin and etoposide. Its main contribution is a structured interpretation of early phase II evidence, highlighting promising response rates while emphasizing that toxicity, disease extent, and the absence of definitive survival comparisons limit conclusions about replacing standard therapy.

• Verapamil HCl as a Mechanistic Probe of Bone Turnover

  2026-09-15

  Verapamil HCl is more than an L-type calcium channel blocker: it can serve as a mechanistic probe linking calcium flux with Txnip-regulated bone remodeling. This guide translates recent osteoporosis findings into better assay design across bone, myeloma, and inflammatory disease models.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-09-15

  Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and related assays. This guide covers handling, assay setup, controls, and troubleshooting; product-specific working dilutions and performance in particular specimens should be established experimentally.

• Imipenem Research Workflows: Setup to Troubleshooting

  2026-09-14

  Build reproducible Imipenem workflows for antibacterial research, immune response modulation, and sepsis animal model studies. The guide combines PBP-centered assay design, water-based preparation, time-course thinking, and troubleshooting for bacterial and host-cell readouts.

• HBsAg, TBK1, and Autophagy in HBV Immune Evasion

  2026-09-14

  The reference study identifies a previously underappreciated mechanism by which hepatitis B surface antigen redirects TBK1 activity away from IRF3-dependent interferon signaling and toward early, incomplete autophagy. Its combination of molecular interaction studies, pharmacological perturbation, animal validation, and human liver-tissue analysis provides a framework for understanding how HBV may establish persistent infection.

• Amikacin (BAY416651) in Resistance Research

  2026-09-13

  A translational framework for using Amikacin (BAY416651) to connect ribosomal mechanism, aminoglycoside resistance, plasmid mobility, and experimental decision-making in carbapenem-resistant Enterobacterales research.

• Nutlin-3a: MDM2 Inhibitor and p53 Tool

  2026-09-12

  Nutlin-3a is a small-molecule MDM2 inhibitor that prevents MDM2 engagement with the TP53-binding pocket and supports p53 pathway activation. Product data report a 0.09 μM MDM2 IC50, while cellular responses vary with p53 status, model, exposure, and assay design.

• Aminopeptidase Selectivity and ACE Inhibitor Action

  2026-09-11

  The reference study re-evaluated how bestatin and several metallopeptidase inhibitors affect the related cell-surface aminopeptidases AP-A, AP-N, and AP-W. Its side-by-side analysis exposed substantial selectivity differences, including preferential AP-N inhibition by actinonin and AP-W inhibition by sulfhydryl ACE inhibitors, which is important when interpreting inhibitor-based experiments.

• Digoxin: Na+/K+ ATPase Research Workflows

  2026-09-11

  Digoxin is a versatile Na+/K+ ATPase pump inhibitor for linking ion transport, cardiac contractility modulation, hypoxia signaling, and cell-type-specific antiviral assays. This workflow-centered guide covers dose selection, controls, endpoint design, and troubleshooting for cardiovascular, thyroid eye disease, and chikungunya research.

• Dehydroepiandrosterone (DHEA) Workflows

  2026-09-10

  Build reproducible DHEA workflows for granulosa-cell inflammation, PCOS modeling, and neuronal stress assays. This guide distinguishes DHEA as a disease-model perturbation in ovarian studies from its neuroprotective and apoptosis-inhibition use in cell-based experiments.

• Praeruptorin A Blocks NF-κB in Poly(I:C) Macrophages

  2026-09-10

  The reference study shows that praeruptorin A suppresses poly(I:C)-induced inflammatory activation in RAW264.7 macrophages, combining RNA sequencing with targeted molecular validation. Its main contribution is to connect transcriptomic enrichment of inflammatory pathways with reduced NF-κB activity and lower expression of selected inflammatory genes, while also defining a concentration range relevant to experimental replication.

• Forsythoside E: PKM2 Inhibitor Workflow

  2026-09-09

  Forsythoside E supports a mechanism-led workflow for connecting PKM2 tetramerization with macrophage metabolism, STAT3 signaling, and inflammatory phenotypes. Its strongest use case is an integrated in vitro-to-in vivo strategy for macrophage M2 polarization and sepsis-induced liver injury research, with practical controls for solubility, serum binding, and pathway validation.

8600 records 7/574 page Previous Next First page 上5页 678910 下5页 Last page